Choong ANG Vaccine Laboratory (072020): Korean Health Care stock

What the company does

Choong ANG Vaccine Laboratory makes vaccines and biological medicines that protect livestock and companion animals from infectious diseases.

Its products are used by livestock farmers and veterinary professionals across South Korea, and it is listed on KOSDAQ, Korea's small-cap and technology exchange. The company's core business is concentrated in biological preparations, vaccines in particular, rather than conventional antibiotic treatments, reflecting a broader industry shift from treating disease to preventing it.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$35.6M

▲ +7.6% YoY

Operating profit · FY2025

US$4.7M

▲ +12.5% YoY

Net income · FY2025

US$4.5M

▼ −10.1% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$30.3M(₩41.9B)	US$33M(₩45.6B)	US$35.6M(₩49.1B)
Operating profit	US$5.1M(₩7B)	US$4.2M(₩5.8B)	US$4.7M(₩6.5B)
Net income	US$4.3M(₩6B)	US$5M(₩6.9B)	US$4.5M(₩6.2B)

Revenue

FY2023US$30.3M
FY2024US$33M
FY2025US$35.6M

Operating profit

FY2023US$5.1M
FY2024US$4.2M
FY2025US$4.7M

Net income

FY2023US$4.3M
FY2024US$5M
FY2025US$4.5M

Key ratios (FY2025)

ROE

5.8%

Debt/Eq

16.6%

Op. margin

13.2%

Net margin

12.6%

Rev. YoY

▲ +7.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?